Astrotech (ASTC) – Business Wire
-
Astrotech Announces Date for Fiscal Year 2022 Annual Meeting and Deadlines for Stockholder Proposals
-
Astrotech Appoints Jim Becker to Board of Directors
-
Astrotech Subsidiary and Cleveland Clinic Expand Breath Analysis Study to Detect Multiple Diseases
-
Astrotech Reports Third Quarter of Fiscal Year 2022 Financial Results
-
Astrotech Reports Second Quarter of Fiscal Year 2022 Financial Results
-
Astrotech Subsidiary BreathTech Hires Dr. Karim Sirgi as Its Chief Science Officer
-
Astrotech Announces Date for Fiscal Year 2021 Annual Meeting and Deadlines for Stockholder Proposals
-
Astrotech Begins Search for Strategic Acquisitions
-
Astrotech Reports First Quarter of Fiscal Year 2022 Financial Results
-
Astrotech Reports Fiscal Year 2021 Financial Results
-
1st Detect Lands First Purchase Order for Checkpoint Security
-
Astrotech Hires Industry Veteran Joe Levinthal to Lead AgLAB’s Science Team
-
Astrotech Reports Third Quarter of Fiscal Year 2021 Financial Results
-
Astrotech Announces Closing of $37.3 Million Bought Deal Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
-
Astrotech Increases Previously Announced Bought Deal Offering of Common Stock to $32.5 Million
-
Astrotech Announces $10 Million Bought Deal Offering of Common Stock
-
Astrotech Subsidiary and Cleveland Clinic Sign Agreement for Breath Analysis Study to Develop a Rapid COVID-19 Breath Test
-
Astrotech Engages Sanmina to Scale Manufacturing
-
Astrotech Reports Second Quarter of Fiscal Year 2021 Financial Results
-
Astrotech Announces Closing of Approximately $9.25 Million Registered Direct Offering Priced At-the-Market
-
Astrotech Announces $9.25 Million Registered Direct Offering Priced At-the-Market
-
Astrotech’s Subsidiary 1st Detect Wins Gold at ‘ASTORS’ Homeland Security Awards as Best CBRNE Detection System
-
Astrotech Reports First Quarter of Fiscal Year 2021 Financial Results
-
Astrotech Announces Closing of $6.2 Million Registered Direct Offering Priced At-the-Market
-
Astrotech Announces $6.2 Million Registered Direct Offering Priced At-the-Market
-
Astrotech’s Subsidiary 1st Detect Surpasses $1 Million in Purchase Orders
-
Astrotech Announces Closing of $18.0 Million Upsized Public Offering
-
Astrotech Announces Pricing of $18.0 Million Upsized Public Offering
-
Astrotech Subsidiary and Cleveland Clinic Partner to Develop a Rapid COVID-19 Breath Test
-
1st Detect’s Tracer 1000™ Achieves Milestone in TSA Air Cargo Screening Qualification Test
-
Astrotech Reports Fiscal Year 2020 Financial Results
-
Astrotech Announces Closing of $3.27 Million Registered Direct Offering Priced At-the-Market
-
Astrotech Announces $3.27 Million Registered Direct Offering Priced At-the-Market
-
Astrotech’s BreathTest-1000 Confirmed to Detect Lung Disease Metabolites at Parts Per Billion
-
Astrotech Announces Closing of $1.77 Million Registered Direct Offering Priced At-the-Market
-
Astrotech Announces $1.77 Million Registered Direct Offering Priced At-the-Market
-
Astrotech Developing Screening Instrument for Lung Diseases Including COVID-19/Coronavirus & Pneumonia
-
Astrotech Reports Second Quarter of Fiscal Year 2020 Financial Results
-
1st Detect Sells TRACER 1000™ Explosives Trace Detectors to Global Shipping and Logistics Company
-
1st Detect’s Tracer 1000™ Deployed in Live Screening at Miami International Airport
-
Astrotech Reports First Quarter of Fiscal Year 2020 Financial Results
-
Astrotech Reports Fiscal Year 2019 Financial Results
-
Astrotech Launches a New Subsidiary and a New Line of Products
Back to ASTC Stock Lookup
